business news

Dr. David Fajgenbaum, one of the founders of Every Cure, a nonprofit focused on drug repurposing. Courtesy of…

Nikolas Kokovlis | Nurphoto | Getty Images Elon Musk’s xAI and its chatbot Grok have been banned from…

Investors may want to take a step back as stocks swing amid rising geopolitical tensions. DBi’s Andrew Beer…

Alphabet has room to run due to Google being well positioned to emerge as a frontrunner in the…

SHENZHEN, CHINA – MARCH 24: Pedestrians walk past a Huawei retail store inside a shopping mall on March…

The USS Tripoli (LHA-7) amphibious assault ship enters the Singapore Straits, amid the U.S.-Israeli conflict with Iran, as…

A trader works on the floor at the New York Stock Exchange (NYSE) in New York City, U.S.,…

Dwayne Schnell | 500px Plus | Getty Images Oil prices fell on Friday after President Donald Trump said…

An oil tanker unloads crude oil at a terminal at the port in Qingdao, in China’s eastern Shandong…

War in Iran and surging oil prices are stoking investors’ fears that inflation is ticking higher, and the…

Stocks to Watch Today: Infosys, Polyplex, Azad Engineering, Sula Vineyards, Aurobindo Pharma, Bharat Dynamics, Brigade Enterprises in focus…

Humanoid robots could be one of the best automation growth opportunities in the next 10 years, and a…

Every Cure’s drug repurposing could change rare disease treatment